146 related articles for article (PubMed ID: 24323884)
1. Polyarginine induces an antitumor immune response through binding to toll-like receptor 4.
Yang Y; Wolfram J; Fang X; Shen H; Ferrari M
Small; 2014 Apr; 10(7):1250-4. PubMed ID: 24323884
[TBL] [Abstract][Full Text] [Related]
2. RETRACTED: Identification of an antitumor immune response of polyhistidine through a toll-like receptor 4-dependent manner.
Wang F; Yang Y
Biochem Biophys Res Commun; 2014 Oct; 453(1):148-52. PubMed ID: 25264106
[TBL] [Abstract][Full Text] [Related]
3. Targeting TLR4 signaling by TLR4 Toll/IL-1 receptor domain-derived decoy peptides: identification of the TLR4 Toll/IL-1 receptor domain dimerization interface.
Toshchakov VY; Szmacinski H; Couture LA; Lakowicz JR; Vogel SN
J Immunol; 2011 Apr; 186(8):4819-27. PubMed ID: 21402890
[TBL] [Abstract][Full Text] [Related]
4. Oxidized curdlan activates dendritic cells and enhances antitumor immunity.
Bao M; Ehexige E; Xu J; Ganbold T; Han S; Baigude H
Carbohydr Polym; 2021 Jul; 264():117988. PubMed ID: 33910726
[TBL] [Abstract][Full Text] [Related]
5. The immunostimulatory effects and pro-apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll-like receptor 4.
Yang J; Zhang H; Zhu Z; Gao Y; Xiang B; Wei Q
Cancer Med; 2019 Aug; 8(9):4441-4453. PubMed ID: 31218844
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 activation in cancer progression and therapy.
Oblak A; Jerala R
Clin Dev Immunol; 2011; 2011():609579. PubMed ID: 22110526
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
[TBL] [Abstract][Full Text] [Related]
8. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
9. Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling.
Zhang H; You X; Wang X; Cui L; Wang Z; Xu F; Li M; Yang Z; Liu J; Huang P; Kang Y; Wu J; Xia X
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33547233
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activator.
Lin YS; Huang LD; Lin CH; Huang PH; Chen YJ; Wong FH; Lin CC; Fu SL
J Biol Chem; 2011 Dec; 286(51):43782-43792. PubMed ID: 21949133
[TBL] [Abstract][Full Text] [Related]
11. Role of toll-like receptor 4 in the inflammation reaction surrounding silicone prosthesis.
Auquit-Auckbur I; Caillot F; Arnoult C; Menard JF; Drouot L; Courville P; Tron F; Musette P
Acta Biomater; 2011 May; 7(5):2047-52. PubMed ID: 21272673
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432.
Okamoto M; Oshikawa T; Tano T; Ohe G; Furuichi S; Nishikawa H; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
J Natl Cancer Inst; 2003 Feb; 95(4):316-26. PubMed ID: 12591988
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-initiated testicular innate immune responses in mouse Leydig cells.
Shang T; Zhang X; Wang T; Sun B; Deng T; Han D
Endocrinology; 2011 Jul; 152(7):2827-36. PubMed ID: 21540291
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy.
Tran TH; Tran TTP; Truong DH; Nguyen HT; Pham TT; Yong CS; Kim JO
Acta Biomater; 2019 Aug; 94():82-96. PubMed ID: 31129358
[TBL] [Abstract][Full Text] [Related]
15. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction.
Michiue H; Tomizawa K; Wei FY; Matsushita M; Lu YF; Ichikawa T; Tamiya T; Date I; Matsui H
J Biol Chem; 2005 Mar; 280(9):8285-9. PubMed ID: 15611109
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor 2, Toll-Like Receptor 4, Myeloid Differentiation Response Gene 88, and Toll-IL-1 Receptor Domain-Containing Adaptor-Inducing Interferon-γ (TRIF) Selectively Regulate Susceptibility of P0
Brunn A; Mihelcic M; Carstov M; Feind L; Wieser EC; Schmidt J; Utermöhlen O; Deckert M
Am J Pathol; 2017 Jan; 187(1):42-54. PubMed ID: 27842213
[TBL] [Abstract][Full Text] [Related]
17. RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling.
Liu B; Zhang N; Liu Z; Fu Y; Feng S; Wang S; Cao Y; Li D; Liang D; Li F; Song X; Yang Z
Mol Cell Biochem; 2013 Jun; 378(1-2):183-93. PubMed ID: 23483427
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
[TBL] [Abstract][Full Text] [Related]
19. Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication.
Zom GG; Willems MMJHP; Khan S; van der Sluis TC; Kleinovink JW; Camps MGM; van der Marel GA; Filippov DV; Melief CJM; Ossendorp F
J Immunother Cancer; 2018 Dec; 6(1):146. PubMed ID: 30541631
[TBL] [Abstract][Full Text] [Related]
20. Ozone enhances pulmonary innate immune response to a Toll-like receptor-2 agonist.
Oakes JL; O'Connor BP; Warg LA; Burton R; Hock A; Loader J; Laflamme D; Jing J; Hui L; Schwartz DA; Yang IV
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):27-34. PubMed ID: 23002100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
